A citation-based method for searching scientific literature

Jenying Deng, Jason B Fleming. Front Cell Dev Biol 2022
Times Cited: 4







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



PD-L1/PD-1 Axis in Glioblastoma Multiforme.
Jakub Litak, Marek Mazurek, Cezary Grochowski, Piotr Kamieniak, Jacek Roliński. Int J Mol Sci 2019
75
25

Multispecific targeting of glioblastoma with tumor microenvironment-responsive multifunctional engineered NK cells.
Jiao Wang, Sandra Toregrosa-Allen, Bennett D Elzey, Sagar Utturkar, Nadia Atallah Lanman, Victor Bernal-Crespo, Matthew M Behymer, Gregory T Knipp, Yeonhee Yun, Michael C Veronesi,[...]. Proc Natl Acad Sci U S A 2021
13
25

Blocking MIR155HG/miR-155 axis inhibits mesenchymal transition in glioma.
Xuechao Wu, Yingyi Wang, Tianfu Yu, Er Nie, Qi Hu, Weining Wu, Tongle Zhi, Kuan Jiang, Xiefeng Wang, Xiaojie Lu,[...]. Neuro Oncol 2017
82
25

m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program.
Sicong Zhang, Boxuan Simen Zhao, Aidong Zhou, Kangyu Lin, Shaoping Zheng, Zhike Lu, Yaohui Chen, Erik P Sulman, Keping Xie, Oliver Bögler,[...]. Cancer Cell 2017
806
25

Epigenetic modulation of metabolism in glioblastoma.
Zhen Dong, Hongjuan Cui. Semin Cancer Biol 2019
47
25

The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
Jiawen Qian, Chen Wang, Bo Wang, Jiao Yang, Yuedi Wang, Feifei Luo, Junying Xu, Chujun Zhao, Ronghua Liu, Yiwei Chu. J Neuroinflammation 2018
112
25

Interleukins in glioblastoma pathophysiology: implications for therapy.
Y T Yeung, K L McDonald, T Grewal, L Munoz. Br J Pharmacol 2013
131
25

The in vivo antitumoral effects of lipopolysaccharide against glioblastoma multiforme are mediated in part by Toll-like receptor 4.
Michael R Chicoine, Michael Zahner, Eun Kyung Won, Ricky R Kalra, Tetsuya Kitamura, Arie Perry, Ryuji Higashikubo. Neurosurgery 2007
68
25

Glioblastoma-activated pericytes support tumor growth via immunosuppression.
Isadora F G Sena, Ana E Paiva, Pedro H D M Prazeres, Patrick O Azevedo, Luiza Lousado, Sujit K Bhutia, Alla B Salmina, Akiva Mintz, Alexander Birbrair. Cancer Med 2018
46
25

Epigenetic Signaling of Cancer Stem Cells During Inflammation.
Zaoqu Liu, Yuqing Ren, Lingfang Meng, Lifeng Li, Richard Beatson, Jinhai Deng, Tengfei Zhang, Junqi Liu, Xinwei Han. Front Cell Dev Biol 2021
5
25

The interplay between glioblastoma and microglia cells leads to endothelial cell monolayer dysfunction via the interleukin-6-induced JAK2/STAT3 pathway.
Marina Couto, Vanessa Coelho-Santos, Liliana Santos, Carlos Fontes-Ribeiro, Ana Paula Silva, Célia M F Gomes. J Cell Physiol 2019
18
25


Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
Nuray Erin, Jelena Grahovac, Anamaria Brozovic, Thomas Efferth. Drug Resist Updat 2020
118
25

Dissecting the role of novel EZH2 inhibitors in primary glioblastoma cell cultures: effects on proliferation, epithelial-mesenchymal transition, migration, and on the pro-inflammatory phenotype.
Giulia Stazi, Ludovica Taglieri, Alice Nicolai, Annalisa Romanelli, Rossella Fioravanti, Stefania Morrone, Manuela Sabatino, Rino Ragno, Samanta Taurone, Marcella Nebbioso,[...]. Clin Epigenetics 2019
32
25

Tenascin C promotes cancer cell plasticity in mesenchymal glioblastoma.
Inbar Angel, Ori Pilo Kerman, Liat Rousso-Noori, Dinorah Friedmann-Morvinski. Oncogene 2020
17
25

GBM-Derived Wnt3a Induces M2-Like Phenotype in Microglial Cells Through Wnt/β-Catenin Signaling.
Diana Matias, Luiz Gustavo Dubois, Bruno Pontes, Luciane Rosário, Valeria Pereira Ferrer, Joana Balça-Silva, Anna Carolina Carvalho Fonseca, Lucy Wanjiku Macharia, Luciana Romão, Tania Cristina Leite de Sampaio E Spohr,[...]. Mol Neurobiol 2019
24
25

HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models.
Trang Thi Thu Nguyen, Yiru Zhang, Enyuan Shang, Chang Shu, Consuelo Torrini, Junfei Zhao, Elena Bianchetti, Angeliki Mela, Nelson Humala, Aayushi Mahajan,[...]. J Clin Invest 2020
48
25

Preclinical Evidence of STAT3 Inhibitor Pacritinib Overcoming Temozolomide Resistance via Downregulating miR-21-Enriched Exosomes from M2 Glioblastoma-Associated Macrophages.
Hao-Yu Chuang, Yu-Kai Su, Heng-Wei Liu, Chao-Hsuan Chen, Shao-Chih Chiu, Der-Yang Cho, Shinn-Zong Lin, Yueh-Sheng Chen, Chien-Min Lin. J Clin Med 2019
42
25

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
25

Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma.
Syreeta DeCordova, Abhishek Shastri, Anthony G Tsolaki, Hadida Yasmin, Lukas Klein, Shiv K Singh, Uday Kishore. Front Immunol 2020
81
25

MiR-223-3p overexpression inhibits cell proliferation and migration by regulating inflammation-associated cytokines in glioblastomas.
Qiuping Ding, Liang Shen, Xiaohu Nie, Bin Lu, Xuyan Pan, Zhongzhou Su, Ai Yan, Renfu Yan, Yue Zhou, Liqin Li,[...]. Pathol Res Pract 2018
34
25

The interplay between metabolic remodeling and immune regulation in glioblastoma.
Pravin Kesarwani, Shiva Kant, Antony Prabhu, Prakash Chinnaiyan. Neuro Oncol 2017
32
25

Multidimensional communication in the microenvirons of glioblastoma.
Marike L Broekman, Sybren L N Maas, Erik R Abels, Thorsten R Mempel, Anna M Krichevsky, Xandra O Breakefield. Nat Rev Neurol 2018
227
25


Pivotal Role of STAT3 in Shaping Glioblastoma Immune Microenvironment.
Christina Piperi, Kostas A Papavassiliou, Athanasios G Papavassiliou. Cells 2019
50
25

Glioblastoma-Associated Microglia Reprogramming Is Mediated by Functional Transfer of Extracellular miR-21.
Erik R Abels, Sybren L N Maas, Lisa Nieland, Zhiyun Wei, Pike See Cheah, Eric Tai, Christy-Joy Kolsteeg, Sophie A Dusoswa, David T Ting, Suzanne Hickman,[...]. Cell Rep 2019
99
25

Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.
Qianghu Wang, Baoli Hu, Xin Hu, Hoon Kim, Massimo Squatrito, Lisa Scarpace, Ana C deCarvalho, Sali Lyu, Pengping Li, Yan Li,[...]. Cancer Cell 2017
763
25

Non-coding RNAs as drug targets.
Masayuki Matsui, David R Corey. Nat Rev Drug Discov 2017
536
25

Glioblastoma genetic drivers dictate the function of tumor-associated macrophages/microglia and responses to CSF1R inhibition.
Rohit Rao, Rong Han, Sean Ogurek, Chengbin Xue, Lai Man Wu, Liguo Zhang, Li Zhang, Jian Hu, Timothy N Phoenix, Stephen N Waggoner,[...]. Neuro Oncol 2022
6
25

Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma.
Wen-Bin Yang, Che-Chia Hsu, Tsung-I Hsu, Jing-Ping Liou, Kwang-Yu Chang, Pin-Yuan Chen, Jr-Jiun Liu, Shung-Tai Yang, Jia-Yi Wang, Shiu-Hwa Yeh,[...]. Neuro Oncol 2020
33
25

Astrocytic trans-Differentiation Completes a Multicellular Paracrine Feedback Loop Required for Medulloblastoma Tumor Growth.
Maojin Yao, P Britten Ventura, Ying Jiang, Fausto J Rodriguez, Lixin Wang, Justin S A Perry, Yibo Yang, Kelsey Wahl, Rowena B Crittenden, Mariko L Bennett,[...]. Cell 2020
57
25

Cancer epigenetics: from mechanism to therapy.
Mark A Dawson, Tony Kouzarides. Cell 2012
25

SAA1 knockdown promotes the apoptosis of glioblastoma cells via downregulation of AKT signaling.
Huikai Zhang, Yang Xu, Gang Deng, Fanen Yuan, Yinqiu Tan, Lun Gao, Qian Sun, Yangzhi Qi, Kun Yang, Rongxin Geng,[...]. J Cancer 2021
4
25

The p38-MK2-HuR pathway potentiates EGFRvIII-IL-1β-driven IL-6 secretion in glioblastoma cells.
F M S Gurgis, Y T Yeung, M X M Tang, B Heng, M Buckland, A J Ammit, J Haapasalo, H Haapasalo, G J Guillemin, T Grewal,[...]. Oncogene 2015
50
25

Prognostic Correlation of Autophagy-Related Gene Expression-Based Risk Signature in Patients with Glioblastoma.
Qiang-Wei Wang, Han-Jie Liu, Zheng Zhao, Ying Zhang, Zheng Wang, Tao Jiang, Zhao-Shi Bao. Onco Targets Ther 2020
24
25

Genomic pathway analysis reveals that EZH2 and HDAC4 represent mutually exclusive epigenetic pathways across human cancers.
Adam L Cohen, Stephen R Piccolo, Luis Cheng, Rafaella Soldi, Bing Han, W Evan Johnson, Andrea H Bild. BMC Med Genomics 2013
29
25

Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma.
Tanwir Hasan, Seamus P Caragher, Jack M Shireman, Cheol H Park, Fatemeh Atashi, Shivani Baisiwala, Gina Lee, Donna Guo, Jennifer Y Wang, Mahua Dey,[...]. Cell Death Dis 2019
33
25

Combined targeting of PDK1 and EGFR triggers regression of glioblastoma by reversing the Warburg effect.
Kiran Kumar Velpula, Arnima Bhasin, Swapna Asuthkar, Andrew J Tsung. Cancer Res 2013
85
25

Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis.
Xin Cui, Renee-Tyler Tan Morales, Weiyi Qian, Haoyu Wang, Jean-Pierre Gagner, Igor Dolgalev, Dimitris Placantonakis, David Zagzag, Luisa Cimmino, Matija Snuderl,[...]. Biomaterials 2018
102
25

Therapeutic Potential of Pharmacological Targeting NLRP3 Inflammasome Complex in Cancer.
Gulcin Tezcan, Ekaterina E Garanina, Mohammad Alsaadi, Zarema E Gilazieva, Ekaterina V Martinova, Maria I Markelova, Svetlana S Arkhipova, Shaimaa Hamza, Alan McIntyre, Albert A Rizvanov,[...]. Front Immunol 2021
10
25

Emerging Roles and Potential Applications of Non-Coding RNAs in Glioblastoma.
Carlos DeOcesano-Pereira, Raquel A C Machado, Ana Marisa Chudzinski-Tavassi, Mari Cleide Sogayar. Int J Mol Sci 2020
9
25

An Inflammatory Landscape for Preoperative Neurologic Deficits in Glioblastoma.
Amal Katrib, Hyun-Hwan Jeong, Nina L Fransen, Kristin S Henzel, Jeremy A Miller. Front Genet 2019
5
25

TP53 gain-of-function mutation promotes inflammation in glioblastoma.
Seok Won Ham, Hee-Young Jeon, Xiong Jin, Eun-Jung Kim, Jun-Kyum Kim, Yong Jae Shin, Yeri Lee, Se Hoon Kim, Seon Yong Lee, Sunyoung Seo,[...]. Cell Death Differ 2019
84
25

Targeting Epigenetics in Cancer.
Richard L Bennett, Jonathan D Licht. Annu Rev Pharmacol Toxicol 2018
115
25

CSF-1R inhibition alters macrophage polarization and blocks glioma progression.
Stephanie M Pyonteck, Leila Akkari, Alberto J Schuhmacher, Robert L Bowman, Lisa Sevenich, Daniela F Quail, Oakley C Olson, Marsha L Quick, Jason T Huse, Virginia Teijeiro,[...]. Nat Med 2013
25

Expression site of P2RY12 in residential microglial cells in astrocytomas correlates with M1 and M2 marker expression and tumor grade.
Changbin Zhu, Johan M Kros, Marcel van der Weiden, PingPin Zheng, Caroline Cheng, Dana A M Mustafa. Acta Neuropathol Commun 2017
45
25

YAP/TAZ Transcriptional Coactivators Create Therapeutic Vulnerability to Verteporfin in EGFR-mutant Glioblastoma.
Krishanthan Vigneswaran, Nathaniel H Boyd, Se-Yeong Oh, Shoeb Lallani, Andrew Boucher, Stewart G Neill, Jeffrey J Olson, Renee D Read. Clin Cancer Res 2021
35
25

Macrophage plasticity and polarization: in vivo veritas.
Antonio Sica, Alberto Mantovani. J Clin Invest 2012
25

p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells.
Yiu To Yeung, Nicole S Bryce, Seray Adams, Nady Braidy, Mari Konayagi, Kerrie L McDonald, Charles Teo, Gilles J Guillemin, Thomas Grewal, Lenka Munoz. J Neurooncol 2012
67
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.